Advertisement

Effect on Outcomes: Infections Complicating Percutaneous Coronary Interventions in Patients ≥80 Years of Age

      Data on the prevalence of infections in patients who underwent percutaneous coronary intervention (PCI) and their impact on outcomes are scarce. In this study, a total of 644 patients ≥80 years of age who underwent PCI were stratified according to the presence/absence of infections requiring antibiotic therapy. The primary end point was major adverse cardiovascular events (MACE) after discharge, a composite of all-cause mortality, nonfatal myocardial infarction, and rehospitalization for heart failure. Median follow-up was 1.2 (interquartile range 0.1 to 3.4) years. Of the 644 patients, 186 (28.9%) had infections during index hospitalization, with 84 (13%) and 59 (9.2%) patients having pneumonia and urinary tract infections, respectively. Patients with infections were older, more often women, and had an increased prevalence of atrial fibrillation and congestive heart failure. Infections prolonged hospital stay (10 [7 to 16] vs 5 [3 to 7] days, p <0.001), but were not related to rates of MACE (20% vs 19%, adjusted hazard ratio [HR] 1.41, 95% confidence intervals 0.84 to 2.38, p = 0.20). Pneumonia was significantly associated with increased rates of MACE (27% vs 18%, adjusted HR 2.19, 95% confidence intervals 1.23 to 3.91, p = 0.008) and rehospitalization for heart failure (17% vs 10%, adjusted HR 2.66 (1.25 to 5.63, p = 0.01), whereas urinary tract infections were not. In conclusion, concomitant infections are frequent in patients ≥80 years of age who underwent PCI, and associated with an increased risk of adverse events when affecting the respiratory system.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Schoenenberger AW
        • Radovanovic D
        • Windecker S
        • Iglesias JF
        • Pedrazzini G
        • Stuck AE
        • Erne P
        • Investigators AP
        Temporal trends in the treatment and outcomes of elderly patients with acute coronary syndrome.
        Eur Heart J. 2016; 37: 1304-1311
        • Sandhu K
        • Nadar SK
        Percutaneous coronary intervention in the elderly.
        Int J Cardiol. 2015; 199: 342-355
        • Gale CP
        • Cattle BA
        • Woolston A
        • Baxter PD
        • West TH
        • Simms AD
        • Blaxill J
        • Greenwood DC
        • Fox KA
        • West RM
        Resolving inequalities in care? Reduced mortality in the elderly after acute coronary syndromes. The Myocardial Ischaemia National Audit Project 2003-2010.
        Eur Heart J. 2012; 33: 630-639
        • Smith LG
        • Herlitz J
        • Karlsson T
        • Berger AK
        • Luepker RV
        International comparison of treatment and long-term outcomes for acute myocardial infarction in the elderly: Minneapolis/St. Paul, MN, USA and Goteborg, Sweden.
        Eur Heart J. 2013; 34: 3191-3197
        • Avezum A
        • Makdisse M
        • Spencer F
        • Gore JM
        • Fox KA
        • Montalescot G
        • Eagle KA
        • White K
        • Mehta RH
        • Knobel E
        • Collet JP
        • Investigators G
        Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE).
        Am Heart J. 2005; 149: 67-73
        • Zaman MJ
        • Stirling S
        • Shepstone L
        • Ryding A
        • Flather M
        • Bachmann M
        • Myint PK
        The association between older age and receipt of care and outcomes in patients with acute coronary syndromes: a cohort study of the Myocardial Ischaemia National Audit Project (MINAP).
        Eur Heart J. 2014; 35: 1551-1558
        • Leistner DM
        • Munch C
        • Steiner J
        • Jakob P
        • Reinthaler M
        • Sinning D
        • Frohlich GM
        • Mochmann HC
        • Rauch-Krohnert U
        • Skurk C
        • Lauten A
        • Landmesser U
        • Stahli BE
        Effect of physical disability on mortality in elderly patients of >/=80 years of age undergoing percutaneous coronary intervention.
        Am J Cardiol. 2018; 122: 537-541
        • Leistner DM
        • Munch C
        • Steiner J
        • Erbay A
        • Riedel M
        • Gebhard C
        • Lauten A
        • Landmesser U
        • Stahli BE
        Impact of acute kidney injury in elderly (>/=80 years) patients undergoing percutaneous coronary intervention.
        J Interv Cardiol. 2018; 31: 792-798
        • Wang HE
        • Moore JX
        • Donnelly JP
        • Levitan EB
        • Safford MM
        Risk of acute coronary heart disease after sepsis hospitalization in the reasons for geographic and racial differences in stroke cohort.
        Clin Infect Dis. 2017; 65: 29-36
        • Corrales-Medina VF
        • Alvarez KN
        • Weissfeld LA
        • Angus DC
        • Chirinos JA
        • Chang CC
        • Newman A
        • Loehr L
        • Folsom AR
        • Elkind MS
        • Lyles MF
        • Kronmal RA
        • Yende S
        Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease.
        JAMA. 2015; 313: 264-274
        • Yende S
        • Linde-Zwirble W
        • Mayr F
        • Weissfeld LA
        • Reis S
        • Angus DC
        Risk of cardiovascular events in survivors of severe sepsis.
        Am J Respir Crit Care Med. 2014; 189: 1065-1074
        • Truffa AA
        • Granger CB
        • White KR
        • Newby LK
        • Mehta RH
        • Hochman JS
        • Patel MR
        • Pieper KS
        • Al-Khalidi HR
        • Armstrong PW
        • Lopes RD
        Serious infection after acute myocardial infarction: incidence, clinical features, and outcomes.
        JACC Cardiovasc Interv. 2012; 5: 769-776
        • Smilowitz NR
        • Gupta N
        • Guo Y
        • Bangalore S
        Comparison of outcomes of patients with sepsis with versus without acute myocardial infarction and comparison of invasive versus noninvasive management of the patients with infarction.
        Am J Cardiol. 2016; 117: 1065-1071
        • Piccaro de Oliveira P
        • Gonzales V
        • Lopes RD
        • Schmidt MM
        • Garofallo S
        • Santos RP
        • Carrion L
        • Gottschall C
        • Quadros AS
        Serious infections among unselected patients with ST-elevation myocardial infarction treated with contemporary primary percutaneous coronary intervention.
        Am Heart J. 2016; 181: 52-59
        • Storey RF
        • James SK
        • Siegbahn A
        • Varenhorst C
        • Held C
        • Ycas J
        • Husted SE
        • Cannon CP
        • Becker RC
        • Steg PG
        • Asenblad N
        • Wallentin L
        Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study.
        Platelets. 2014; 25: 517-525
        • Montalescot G
        • Sechtem U
        • Achenbach S
        • Andreotti F
        • Arden C
        • Budaj A
        • Bugiardini R
        • Crea F
        • Cuisset T
        • Di Mario C
        • Ferreira JR
        • Gersh BJ
        • Gitt AK
        • Hulot JS
        • Marx N
        • Opie LH
        • Pfisterer M
        • Prescott E
        • Ruschitzka F
        • Sabate M
        • Senior R
        • Taggart DP
        • van der Wall EE
        • Vrints CJ
        • Guidelines ESCCfP
        • Zamorano JL
        • Achenbach S
        • Baumgartner H
        • Bax JJ
        • Bueno H
        • Dean V
        • Deaton C
        • Erol C
        • Fagard R
        • Ferrari R
        • Hasdai D
        • Hoes AW
        • Kirchhof P
        • Knuuti J
        • Kolh P
        • Lancellotti P
        • Linhart A
        • Nihoyannopoulos P
        • Piepoli MF
        • Ponikowski P
        • Sirnes PA
        • Tamargo JL
        • Tendera M
        • Torbicki A
        • Wijns W
        • Windecker S
        • Document R
        • Knuuti J
        • Valgimigli M
        • Bueno H
        • Claeys MJ
        • Donner-Banzhoff N
        • Erol C
        • Frank H
        • Funck-Brentano C
        • Gaemperli O
        • Gonzalez-Juanatey JR
        • Hamilos M
        • Hasdai D
        • Husted S
        • James SK
        • Kervinen K
        • Kolh P
        • Kristensen SD
        • Lancellotti P
        • Maggioni AP
        • Piepoli MF
        • Pries AR
        • Romeo F
        • Ryden L
        • Simoons ML
        • Sirnes PA
        • Steg PG
        • Timmis A
        • Wijns W
        • Windecker S
        • Yildirir A
        • Zamorano JL
        2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology.
        Eur Heart J. 2013; 34: 2949-3003
        • Roffi M
        • Patrono C
        • Collet JP
        • Mueller C
        • Valgimigli M
        • Andreotti F
        • Bax JJ
        • Borger MA
        • Brotons C
        • Chew DP
        • Gencer B
        • Hasenfuss G
        • Kjeldsen K
        • Lancellotti P
        • Landmesser U
        • Mehilli J
        • Mukherjee D
        • Storey RF
        • Windecker S
        • Baumgartner H
        • Gaemperli O
        • Achenbach S
        • Agewall S
        • Badimon L
        • Baigent C
        • Bueno H
        • Bugiardini R
        • Carerj S
        • Casselman F
        • Cuisset T
        • Erol C
        • Fitzsimons D
        • Halle M
        • Hamm C
        • Hildick-Smith D
        • Huber K
        • Iliodromitis E
        • James S
        • Lewis BS
        • Lip GY
        • Piepoli MF
        • Richter D
        • Rosemann T
        • Sechtem U
        • Steg PG
        • Vrints C
        • Luis Zamorano J
        2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC).
        Eur Heart J. 2016; 37: 267-315
        • Steg PG
        • James SK
        • Atar D
        • Badano LP
        • Blomstrom-Lundqvist C
        • Borger MA
        • Di Mario C
        • Dickstein K
        • Ducrocq G
        • Fernandez-Aviles F
        • Gershlick AH
        • Giannuzzi P
        • Halvorsen S
        • Huber K
        • Juni P
        • Kastrati A
        • Knuuti J
        • Lenzen MJ
        • Mahaffey KW
        • Valgimigli M
        • van 't Hof A
        • Widimsky P
        • Zahger D
        • Task Force on the management of STseamiotESoC
        ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.
        Eur Heart J. 2012; 33: 2569-2619
      1. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators.
        New Engl J Med. 1993; 329: 673-682
        • Smeeth L
        • Thomas SL
        • Hall AJ
        • Hubbard R
        • Farrington P
        • Vallance P
        Risk of myocardial infarction and stroke after acute infection or vaccination.
        New Engl J Med. 2004; 351: 2611-2618
        • Cesari M
        • Penninx BW
        • Newman AB
        • Kritchevsky SB
        • Nicklas BJ
        • Sutton-Tyrrell K
        • Rubin SM
        • Ding J
        • Simonsick EM
        • Harris TB
        • Pahor M
        Inflammatory markers and onset of cardiovascular events: results from the Health ABC study.
        Circulation. 2003; 108: 2317-2322
        • Yende S
        • D'Angelo G
        • Kellum JA
        • Weissfeld L
        • Fine J
        • Welch RD
        • Kong L
        • Carter M
        • Angus DC
        • Gen IMSI
        Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis.
        Am J Respir Crit Care Med. 2008; 177: 1242-1247
        • Stahli BE
        • Yonekawa K
        • Altwegg LA
        • Wyss C
        • Hof D
        • Fischbacher P
        • Brauchlin A
        • Schulthess G
        • Krayenbuhl PA
        • von Eckardstein A
        • Hersberger M
        • Neidhart M
        • Gay S
        • Novopashenny I
        • Wolters R
        • Frank M
        • Wischnewsky MB
        • Luscher TF
        • Maier W
        Clinical criteria replenish high-sensitive troponin and inflammatory markers in the stratification of patients with suspected acute coronary syndrome.
        PLoS One. 2014; 9: e98626
        • Yende S
        • D'Angelo G
        • Mayr F
        • Kellum JA
        • Weissfeld L
        • Kaynar AM
        • Young T
        • Irani K
        • Angus DC
        • Gen IMSI
        Elevated hemostasis markers after pneumonia increases one-year risk of all-cause and cardiovascular deaths.
        PLoS One. 2011; 6: e22847
        • Merx MW
        • Weber C
        Sepsis and the heart.
        Circulation. 2007; 116: 793-802
        • Milbrandt EB
        • Reade MC
        • Lee M
        • Shook SL
        • Angus DC
        • Kong L
        • Carter M
        • Yealy DM
        • Kellum JA
        • Gen IMSI
        Prevalence and significance of coagulation abnormalities in community-acquired pneumonia.
        Mol Med. 2009; 15: 438-445